Serum acid phosphatase activity in diabetes mellitus. 1973

F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003925 Diabetic Angiopathies VASCULAR DISEASES that are associated with DIABETES MELLITUS. Diabetic Vascular Complications,Diabetic Vascular Diseases,Microangiopathy, Diabetic,Angiopathies, Diabetic,Angiopathy, Diabetic,Diabetic Angiopathy,Diabetic Microangiopathies,Diabetic Microangiopathy,Diabetic Vascular Complication,Diabetic Vascular Disease,Microangiopathies, Diabetic,Vascular Complication, Diabetic,Vascular Complications, Diabetic,Vascular Disease, Diabetic,Vascular Diseases, Diabetic
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
November 1984, The Journal of the Association of Physicians of India,
F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
January 1986, Journal of the American College of Nutrition,
F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
February 1977, Clinical biochemistry,
F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
January 1981, Endokrynologia Polska,
F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
July 1980, Clinica chimica acta; international journal of clinical chemistry,
F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
January 1972, Journal des sciences medicales de Lille,
F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
February 1981, Diabetes,
F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
August 1971, Rinsho byori. The Japanese journal of clinical pathology,
F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
February 1988, Diabetes research (Edinburgh, Scotland),
F Belfiore, and E Napoli, and L L Vecchio, and A M Rabuazzo
February 1969, American journal of clinical pathology,
Copied contents to your clipboard!